Literature DB >> 7310646

Metabolite to parent drug concentration ratio as a function of parent drug extraction ratio: cases of nonportal route of administration.

E A Lane, R H Levy.   

Abstract

The ratio of metabolite to parent drug concentration (Cm/Cp) of a medium or high extraction ratio (E greater than 0.1) drug administered intravenously has been shown to depend on intrinsic clearance of drug by other metabolic routes (CLr,int) as well as on organ blood flow (Q). In contrast, for a low extraction ratio drug given intravenously or for any drug given by a portal route, this ratio is equal to the ratio of formation clearance (CLf,int) and metabolite clearance (CLm,int). The sensitivity of Cm/Cp to changes in CLr,int and CLf,int has been analyzed quantitatively. It was shown to be dependent on the fraction metabolized to that particular metabolite (fm).

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7310646     DOI: 10.1007/bf01060891

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  9 in total

1.  Kinetics of biotransformation of clonazepam to its 7-amino metabolite in the monkey.

Authors:  A A Lai; B H Min; W A Garland; R H Levy
Journal:  J Pharmacokinet Biopharm       Date:  1979-02

Review 2.  Altered hepatic blood flow and drug disposition.

Authors:  A S Nies; D G Shand; G R Wilkinson
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

3.  Pharmacokinetics of carbamazepine-10,11- epoxide before and after autoinduction in rhesus monkeys.

Authors:  I H Patel; R H Levy; W F Trager
Journal:  J Pharmacol Exp Ther       Date:  1978-09       Impact factor: 4.030

4.  Pharmacokinetic description of drug interactions by enzyme induction: carbamazepine-clonazepam in monkeys.

Authors:  A A Lai; R H Levy
Journal:  J Pharm Sci       Date:  1979-04       Impact factor: 3.534

5.  Prediction of steady-state behavior of metabolite from dosing of parent drug.

Authors:  E A Lane; R H Levy
Journal:  J Pharm Sci       Date:  1980-05       Impact factor: 3.534

6.  Time-dependent kinetics I: Exponential autoinduction of carbamazepine in monkeys.

Authors:  W H Pitlick; R H Levy
Journal:  J Pharm Sci       Date:  1977-05       Impact factor: 3.534

7.  Hepatic clearance of drugs. I. Theoretical considerations of a "well-stirred" model and a "parallel tube" model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearance.

Authors:  K S Pang; M Rowland
Journal:  J Pharmacokinet Biopharm       Date:  1977-12

8.  Sequential first-pass elimination of a metabolite derived from a precursor.

Authors:  K S Pang; J R Gillette
Journal:  J Pharmacokinet Biopharm       Date:  1979-06

9.  Interindividual differences in amitriptyline demethylation.

Authors:  D E Rollins; G Alván; L Bertilsson; J R Gillette; B Mellström; F Sjöqvist; L Träskman
Journal:  Clin Pharmacol Ther       Date:  1980-07       Impact factor: 6.875

  9 in total
  4 in total

1.  Physiological modeling of drug and metabolite: disposition of oxazepam and oxazepam glucuronides in the recirculating perfused mouse liver preparation.

Authors:  M V St-Pierre; D van den Berg; K S Pang
Journal:  J Pharmacokinet Biopharm       Date:  1990-10

2.  Primary, secondary, and tertiary metabolite kinetics.

Authors:  M V St-Pierre; X Xu; K S Pang
Journal:  J Pharmacokinet Biopharm       Date:  1988-10

Review 3.  Effects of ethanol on drug and metabolite pharmacokinetics.

Authors:  E A Lane; S Guthrie; M Linnoila
Journal:  Clin Pharmacokinet       Date:  1985 May-Jun       Impact factor: 6.447

Review 4.  A review of metabolite kinetics.

Authors:  K S Pang
Journal:  J Pharmacokinet Biopharm       Date:  1985-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.